Plain-English translation of NCT05712824 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the V-LAP System, a small wireless implant that sits in your heart and measures the pressure inside the left side of your heart. The implant sends daily pressure readings to your home, and you'll use a smartphone app to help manage your heart failure treatment under your doctor's guidance. The goal is to catch problems early and reduce hospitalizations.
Heart failure patients often don't realize their condition is worsening until they need emergency care. This treatment aims to give patients and doctors real-time information about heart pressure so they can adjust medications early and avoid hospital visits.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have a procedure to implant the wireless device through a catheter inserted into a vein in your groin—similar to other heart procedures but less invasive than surgery. After the implant, you'll take daily pressure readings at home using the device and a smartphone app, which will guide you on when to adjust your medications (with your doctor's approval) or contact your care team. The trial will monitor your safety and track whether this approach reduces your hospitalizations and improves your quality of life.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Georgia